Form 4: Savers Value Village General Counsel Exercises Options and Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Savers Value Village General Counsel Richard A. Medway exercised stock options and subsequently sold the acquired shares for a significant gain, as part of a pre-arranged 10b5-1 trading plan.
Summary
- Richard A. Medway, General Counsel of Savers Value Village, Inc., executed a transaction on July 3, 2025, involving the company's common stock.
- Medway exercised options to acquire 17,619 shares of common stock at an exercise price of $1.41 per share.
- Immediately following the exercise, all 17,619 shares were sold at a price of $10.65 per share.
- The sale was conducted pursuant to a Rule 10b5-1 trading plan, which was adopted by the reporting person on September 13, 2024.
- After these reported transactions, Medway directly holds 0 shares of common stock from this specific transaction, but retains 504,256 derivative securities (options).
- The exercised options were part of a grant from June 12, 2019, under the Registrant's 2019 Management Incentive Plan, which fully vested by March 28, 2024.
- The remaining options consist of approximately 36% time-based options with a vesting schedule that began March 28, 2020, and approximately 64% performance-based options, of which 25% vested upon the initial public offering and the remainder are eligible for vesting upon satisfaction of certain stock price performance criteria.
Sentiment
Score: 6
Explanation: Neutral to slightly positive. While it's an insider sale, it's pre-planned via a 10b5-1 plan, which mitigates negative sentiment. The significant gain from option exercise is positive for the individual, but the sale itself doesn't inherently signal strong positive company performance.
Positives
- The transaction demonstrates a significant financial gain for the insider, as shares acquired at $1.41 were sold at $10.65, representing a substantial profit per share.
- The sale was conducted under a pre-arranged 10b5-1 plan, which indicates a planned transaction for personal financial management rather than an immediate reaction to new, undisclosed company information.
Negatives
- An insider sale, even if pre-planned, reduces the insider's direct equity stake in the company, which can sometimes be perceived neutrally or slightly negatively by the market.
Future Outlook
The document does not provide forward-looking statements or guidance regarding the company's future performance, focusing solely on an insider's transaction.
Management Comments
- The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on September 13, 2024.
- Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions.
- The June 12, 2019, stock option grant vested in substantially equal annual installments over five years starting March 28, 2020, until fully vested on March 28, 2024.
- Approximately 36% represents time-based options with a vesting schedule in substantially equal annual installments over five years starting March 28, 2020, and approximately 64% represents performance-based options, of which 25% vested upon the initial public offering and the remainder will be eligible for vesting upon satisfaction of certain performance criteria including stock price performance.
Industry Context
This Form 4 filing is a routine disclosure of an insider transaction and does not provide information directly related to broader industry trends or the competitive landscape. Insider transactions are common across all industries as part of executive compensation and personal financial planning.
Comparison to Industry Standards
- This document is a standard insider transaction report (Form 4) and does not contain information that allows for a direct comparison of company performance against industry benchmarks or specific comparable companies/projects.
- The transaction itself, an exercise and sale under a 10b5-1 plan, is a common practice for executives managing their equity compensation and is consistent with typical insider trading disclosures.
Stakeholder Impact
- Shareholders: May observe an insider reducing direct shareholding, though this is mitigated by the transaction being part of a pre-arranged 10b5-1 plan, suggesting a planned financial event rather than a reaction to new company news.
- Employees: No direct impact on employees is mentioned in this transaction report.
- Customers: No direct impact on customers is mentioned in this transaction report.
- Suppliers: No direct impact on suppliers is mentioned in this transaction report.
- Creditors: No direct impact on creditors is mentioned in this transaction report.
Key Dates
| Date | Description |
|---|---|
| 2019-06-12 | Date of stock option grant under the 2019 Management Incentive Plan. |
| 2020-03-28 | Start date for annual installments of time-based option vesting. |
| 2024-03-28 | Date when the June 12, 2019 stock option grant fully vested. |
| 2024-09-13 | Date the 10b5-1 Plan was adopted by the reporting person. |
| 2025-07-03 | Date of option exercise and subsequent sale of common stock. |
| 2025-07-08 | Signature date of the reporting person on the Form 4. |
| 2029-06-12 | Expiration date of the derivative securities (options). |
Recommendation
holdKeywords
Savers Value Village, SVV, Form 4, Insider Trading, Stock Options, 10b5-1 Plan, Richard Medway, General Counsel, Equity Compensation, Share Sale
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.